• Saturday, Nov 27, 2021
  • Last Update : 01:11 pm

Patient critical after reinfection with S African variant

  • Published at 05:39 pm February 13th, 2021
France Covid-19
File Photo: Medical staff members in the Intensive Care Unit for Covid-19 patients at La Timone hospital in Marseille, France on February 8, 2021 Reuters

The 501Y.V2 coronavirus variant emerged late last year in South Africa and immediately provoked alarm among disease specialists

Doctors in France are treating a critically ill patient infected with the South African coronavirus variant, four months after he recovered from Covid-19, in what study authors said was the first case of its kind.

The 58-year-old man had a history of asthma and initially tested positive for Covid-19 in September when he presented to medical staff with a fever and shortness of breath.

The symptoms persisted only for a few days, and the man tested negative for Covid-19 twice in December 2020.

However, he was admitted to hospital in January and diagnosed with the South African variant.

The patient's condition worsened, and he is currently in a "critical condition" on a ventilator.

"This is, to our knowledge, the first description of reinfection with the South African (variant) causing severe Covid-19, four months after a first mild infection," said authors of a study published this week in the journal Clinical Infectious Diseases.

The 501Y.V2 coronavirus variant emerged late last year in South Africa and immediately provoked alarm among disease specialists. 

It has eight key mutations, one of which affects the virus' spike protein, making it more effective at binding to human cells and therefore more infectious.

Vaccine manufacturers Pfizer/BioNTech and Moderna say their mRNA vaccines retain their effectiveness against the South African variants and another that emerged last year in Britain.

However, a study last week showed that AstraZeneca's vaccine failed to prevent mild and moderate cases of infection of the South African variant.

"The impact of 501Y.V2 mutations on the effectiveness of vaccines developed based on earlier SARS-CoV-2 strains is still unknown," said the authors of the reinfection study.

52
Facebook 51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail